Artificial Intelligence in Pharmaceutics and Drug Delivery: Current Applications and Future Perspectives
Abstract
Artificial intelligence (AI) is rapidly reshaping pharmaceutics and drug delivery, offering computational alternatives to traditional trial-and-error approaches in formulation design, nanocarrier engineering, and manufacturing. This review examines the current applications of machine learning, deep learning, reinforcement learning, and generative AI architectures across the pharmaceutical product lifecycle, from target identification and lead optimization to dosage form development and clinical translation. Particular attention is given to AI-driven prediction of excipient compatibility, formulation stability, and bioavailability, as well as the design of smart nanocarriers, stimuli-responsive delivery systems, and 3D-printed dosage forms enabled by graph neural networks, transformer-based models, and Bayesian optimization techniques. The review also traces the historical evolution of computational pharmaceutics, from early rule-based prediction systems to current high-throughput, automation-integrated platforms, and highlights emerging tools such as digital twins, federated learning frameworks, and AI-supported nanorobotics for targeted intracellular delivery. Despite these advances, significant challenges persist, including limited data availability and standardization, algorithmic opacity and the demand for explainable AI, and the absence of harmonized regulatory frameworks for validating AI-driven decision-making in drug development. The review further considers data quality and interpretability concerns specific to nanomedicine, alongside the regulatory and ethical considerations necessary for clinical adoption. Future directions emphasize the integration of multi-omics data, real-time adaptive drug delivery systems, and quantum-AI convergence to advance personalized medicine. Addressing these barriers through interdisciplinary collaboration, standardized data repositories, and transparent regulatory guidance will be essential to translating AI-enabled pharmaceutical innovations from computational design into safe, effective clinical therapeutics.
Keywords: Artificial intelligence; machine learning; drug delivery; nanomedicine; formulation design; personalized medicine; deep learning; pharmaceutics
Keywords:
Artificial intelligence, machine learning;, Drug delivery, nanomedicine, formulation design, personalized medicine, deep learning, pharmaceuticsDOI
https://doi.org/10.22270/jddt.v16i7.7845References
1. Serrano DR, Luciano FC, Anaya BJ, Öngoren B, Kara A, Molina G, et al. Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics [Internet]. 2024 Oct 14 [cited 2026 Mar];16(10):1328–1328. Available from: https://doi.org/10.3390/pharmaceutics16101328
2. SHahreza MS, Naeimi F. A Mini-Review on Machine Learning Framework for Drug Delivery Applications. Journal of advanced materials and processing [Internet]. 2026 Feb 2 [cited 2026 Feb]; Available from: https://doi.org/10.71670/jmatpro.2024.1232710
3. B SDM, Kamala G, G H, M AVDSP, N SSD, Ketha J. Utilization of Artificial Intelligence in Pharmaceutical Sciences for Teaching, Learning, and Clinical Practice. Journal of Pharma Insights and Research [Internet]. 2026 Feb 5 [cited 2026 Mar];4(1):69–77. Available from: https://doi.org/10.69613/dw5jnw67
4. Vora LK, Gholap AD, Jetha K, Singh TRR, Solanki HK, Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics [Internet]. 2023 July 10 [cited 2026 Jan];15(7):1916–1916. Available from: https://doi.org/10.3390/pharmaceutics15071916
5. Darekar PB Krushi Pradhan, Janvi Patil, Dr Avinash. Artificial Intelligence in Drug Delivery Systems: Revolutionizing Pharmaceutical Formulation, Optimization, and Personalized Therapeutics. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 14 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17611150
6. Wu Y, Wang N, Xiong P, Wang R, Deng J, Ouyang D. Artificial intelligence for drug delivery: Yesterday, today and tomorrow. Acta Pharmaceutica Sinica B [Internet]. 2025 Sept 1 [cited 2026 Feb]; Available from: https://doi.org/10.1016/j.apsb.2025.09.022
7. Darekar PB Krushi Pradhan, Janvi Patil, Dr Avinash. Artificial Intelligence in Drug Delivery Systems: Revolutionizing Pharmaceutical Formulation, Optimization, and Personalized Therapeutics. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 14 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17611149
8. Swami AAS, Shruti SS, Kansal PK, S GS, Bhide AB. Artificial Intelligence in Pharmacology and Pharmaceutics: From Drug Discovery to Clinical Translation. Journal of Pharmaceutical Research and Integrated Medical Sciences [Internet]. 2026 Mar 17 [cited 2026 Mar];17–31. Available from: https://doi.org/10.64063/3049-1681.vol.3.issue3.2
9. Zhu T, Liu B, Chen N, Liu Y, Wang Z, Xue T. Artificial Intelligence-Driven Innovations in Pharmaceutical Development and Drug Delivery Systems. Current Topics in Medicinal Chemistry [Internet]. 2025 Apr 25 [cited 2025 Nov];25(25):2937–51. Available from: https://doi.org/10.2174/0115680266373236250411060857
10. Noorain, Srivastava V, Parveen B, Parveen R. Artificial Intelligence in Drug Formulation and Development: Applications andFuture Prospects. Current Drug Metabolism [Internet]. 2023 Sept 1 [cited 2026 Feb];24(9):622–34. Available from: https://doi.org/10.2174/0113892002265786230921062205
11. Joshi S, Sheth S. Artificial Intelligence (AI) in Pharmaceutical Formulation and Dosage Calculations. Pharmaceutics [Internet]. 2025 Nov 7 [cited 2026 Mar];17(11):1440–1440. Available from: https://doi.org/10.3390/pharmaceutics17111440
12. Gouma AGA, Alhaj AAK, Karar OMFA, Mahgoub MAI, Saleh A. The convergence of AI and pharmaceutics a new era of data-driven drug development. International Journal of Science and Research Archive [Internet]. 2025 Feb 18 [cited 2025 Dec];14(2):947–60. Available from: https://doi.org/10.30574/ijsra.2025.14.2.0478
13. Aundhia C, Parmar G, Talele C, Shah N, Talele D. Impact of Artificial Intelligence on Drug Development and Delivery. Current Topics in Medicinal Chemistry [Internet]. 2024 Aug 13 [cited 2025 Nov];25(10):1165–84. Available from: https://doi.org/10.2174/0115680266324522240725053634
14. kawale* K patil A. Applications of Artificial Intelligence in Pharmaceutical Sciences: A Review. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Feb 3 [cited 2026 Feb]; Available from: https://doi.org/10.5281/zenodo.18464413
15. Jena GK, Patra CN, Jammula S, Parhi R, Chand S. Artificial Intelligence and Machine Learning Implemented Drug Delivery Systems: A Paradigm Shift in the Pharmaceutical Industry. Journal of Bio-X Research [Internet]. 2024 Jan 1 [cited 2025 Dec];7. Available from: https://doi.org/10.34133/jbioxresearch.0016
16. Jadge VP Sonam Babaso Kamble, Dr Dhanraj Raghunath. Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 8 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17556719
17. Jadge VP Sonam Babaso Kamble, Dr Dhanraj Raghunath. Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 8 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17556720
18. Bhelkar N. Role of Artificial Intelligence in Formulation Design. International Journal For Multidisciplinary Research [Internet]. 2026 Jan 30 [cited 2026 Mar];8(1). Available from: https://doi.org/10.36948/ijfmr.2026.v08i01.67247
19. Pawar V, Patil A, Tamboli FA, Gaikwad D, Mali DP, Shinde AJ. Harnessing the Power of AI in Pharmacokinetics and Pharmacodynamics: A Comprehensive Review. International Journal of Pharmaceutical Quality Assurance [Internet]. 2023 June 25 [cited 2025 Oct];14(2):426–39. Available from: https://doi.org/10.25258/ijpqa.14.2.31
20. Petković K, Strika Z, Likić R, Lucijanić M. Spotlight commentary: Integrating artificial intelligence in clinical pharmacology: Opportunities, challenges and ethical imperatives. British Journal of Clinical Pharmacology [Internet]. 2024 Sept 5 [cited 2026 Mar];90(11):2700–4. Available from: https://doi.org/10.1111/bcp.16241
21. Elmahboub Y, Albash R, Ahmed S, Salah S. The Road to Precision Nanomedicine: An Insight on Drug Repurposing and Advances in Nanoformulations for Treatment of Cancer. AAPS PharmSciTech [Internet]. Springer Science+Business Media; 2025 Oct 6 [cited 2025 Oct];26(8). Available from: https://doi.org/10.1208/s12249-025-03233-1
22. Sarhan OM, Gebril MI, Elsegaie D. Artificial intelligence-enabled nanomedicine: enhancing drug design and predictive modeling in pharmaceutics. Journal of Pharmacy and Pharmacology [Internet]. 2025 Oct 23 [cited 2026 Mar];78(3). Available from: https://doi.org/10.1093/jpp/rgaf113
23. Mishra N, Dasari A. Artificial intelligence and 3D printing in pharmaceuticals: A new frontier in personalized drug manufacturing. International Journal of Pharmacy and Pharmaceutical Science [Internet]. 2025 Jan 1 [cited 2025 Nov];7(2):15–22. Available from: https://doi.org/10.33545/26647222.2025.v7.i2a.188
24. Suksaeree J. A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm. Sci [Internet]. 2025 Dec 3 [cited 2026 Mar];7(4):179–179. Available from: https://doi.org/10.3390/sci7040179
25. Akhtar M, Nehal N, Gull A, Parveen R, Khan SI, Khan SI, et al. Explicating the transformative role of artificial intelligence in designing targeted nanomedicine. Expert Opinion on Drug Delivery [Internet]. 2025 May 5 [cited 2026 Mar];22(7):971–91. Available from: https://doi.org/10.1080/17425247.2025.2502022
26. Kataria S. AI-Guided Design of Personalized Nanomedicine: A Review of Data-Driven Approaches in Nanoparticle Formulation. International Journal For Multidisciplinary Research [Internet]. 2025 Aug 13 [cited 2025 Dec];7(4). Available from: https://doi.org/10.36948/ijfmr.2025.v07i04.53283
27. Ros H, Chan N, Cook MT, Shorthouse D. Artificial intelligence and machine learning guided optimization in drug delivery. Advanced Drug Delivery Reviews [Internet]. 2026 Jan 22 [cited 2026 Mar];232:115781–115781. Available from: https://doi.org/10.1016/j.addr.2026.115781
28. Sun L, Liu H, Ye Y, Yang L, Islam R, Tan S, et al. Smart nanoparticles for cancer therapy. Signal Transduction and Targeted Therapy [Internet]. Springer Nature; 2023 Nov 3 [cited 2025 Aug];8(1). Available from: https://doi.org/10.1038/s41392-023-01642-x
29. Nag S, Ong YS, Narayanan K, Subramaniyan V, Naidu R. Mechanistic Insights into Nanomaterials and Advanced Drug Delivery Platforms for the Theranostic Management of Hepatic Cancer: A Comprehensive Update. BioNanoScience [Internet]. 2025 Oct 20 [cited 2025 Oct];15(4). Available from: https://doi.org/10.1007/s12668-025-02175-z
30. Das KP, Chandra J. Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges. Frontiers in Medical Technology [Internet]. Frontiers Media; 2023 Jan 6 [cited 2025 Oct];4. Available from: https://doi.org/10.3389/fmedt.2022.1067144
31. Castro BM, Elbadawi M, Ong JJ, Pollard TD, Song Z, Gaisford S, et al. Machine learning predicts 3D printing performance of over 900 drug delivery systems. Journal of Controlled Release [Internet]. 2021 July 30 [cited 2025 Aug];337:530–45. Available from: https://doi.org/10.1016/j.jconrel.2021.07.046
32. Dey H, Arya N, Mathur H, Chatterjee N, Jadon R. Exploring the Role of Artificial Intelligence and Machine Learning in Pharmaceutical Formulation Design. International Journal of Newgen Research in Pharmacy & Healthcare [Internet]. 2024 June 30 [cited 2026 Mar];30–41. Available from: https://doi.org/10.61554/ijnrph.v2i1.2024.67
33. Kapoor DU, Sharma JB, Gandhi S, Prajapati BG, Thanawuth K, Limmatvapirat S, et al. AI-driven design and optimization of nanoparticle-based drug delivery systems. Science, Engineering and Health Studies [Internet]. 2024 Dec 6 [cited 2025 Oct];24010003–24010003. Available from: https://doi.org/10.69598/sehs.18.24010003
34. Heydari S, Masoumi N, Esmaeeli E, Ayyoubzadeh SM, Ghorbani‐Bidkorbeh F, Ahmadi M. Artificial intelligence in nanotechnology for treatment of diseases. Journal of drug targeting [Internet]. 2024 Aug 19 [cited 2025 Nov];32(10):1247–66. Available from: https://doi.org/10.1080/1061186x.2024.2393417
35. Ali KA, Mohin S, Mondal P, Goswami S, Ghosh S, Choudhuri S. Influence of artificial intelligence in modern pharmaceutical formulation and drug development. Future Journal of Pharmaceutical Sciences [Internet]. 2024 Mar 29 [cited 2025 Oct];10(1). Available from: https://doi.org/10.1186/s43094-024-00625-1
36. Sushma M, Venkatappa BB, Chakrapani B, Babu MCL, Goruntla N. AI-Driven Nanopharmacology: Intelligent Nano systems Transforming Drug Discovery and Therapeutic Delivery. International Journal of Pharma Growth Research Review [Internet]. 2025 Jan 1 [cited 2026 Mar];2(6):12–9. Available from: https://doi.org/10.54660/ijpgrr.2025.2.6.12-19
37. Sanjay KD, Gadekar PS, Patil KVT. Transforming Drug Discovery: The Impact of Artificial Intelligence and Machine Learning from Initial Screening to Clinical Trials. International Journal for Research in Applied Science and Engineering Technology [Internet]. 2024 Aug 15 [cited 2025 Oct];12(8):503–8. Available from: https://doi.org/10.22214/ijraset.2024.63936
38. Chou W, Canchola A, Zhang F, Lin Z. Machine Learning and Artificial Intelligence in Nanomedicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology [Internet]. 2025 July 1 [cited 2026 Mar];17(4). Available from: https://doi.org/10.1002/wnan.70027
39. Sultana A, Maseera R, Rahamanulla A, Misiriya A. Emerging of artificial intelligence and technology in pharmaceuticals: review. Future Journal of Pharmaceutical Sciences [Internet]. 2023 Aug 8 [cited 2025 Sept];9(1). Available from: https://doi.org/10.1186/s43094-023-00517-w
40. Garg S, Arora K, Singh S, Nagarajan K. Artificial Intelligence and Machine Learning in Drug Discovery and Development. In: Advances in computational intelligence and robotics book series [Internet]. IGI Global; 2023 [cited 2025 Nov]. p. 42–61. Available from: https://doi.org/10.4018/979-8-3693-0368-9.ch003
41. Pandey V. Artificial Intelligence and Machine Learning in Drug Discovery: Transformative Applications and Interdisciplinary Integration with Nanotechnology and Robotics. International Journal For Multidisciplinary Research [Internet]. 2025 Oct 9 [cited 2026 Mar];7(5). Available from: https://doi.org/10.36948/ijfmr.2025.v07i05.57130
42. Gupta K, Sharma M, Sharma I, Shukla S. Next-Generation Pharmaceutics: AI-Assisted Drug Design, Nanotechnology, and Advanced Therapeutic Delivery Systems [Internet]. Zenodo (CERN European Organization for Nuclear Research). European Organization for Nuclear Research; 2025 [cited 2026 Mar]. Available from: https://doi.org/10.5281/zenodo.18815117
43. Gupta K, Sharma M, Sharma I, Shukla S. Next-Generation Pharmaceutics: AI-Assisted Drug Design, Nanotechnology, and Advanced Therapeutic Delivery Systems [Internet]. Zenodo (CERN European Organization for Nuclear Research). European Organization for Nuclear Research; 2025 [cited 2026 Mar]. Available from: https://doi.org/10.5281/zenodo.18815118
44. Mottaghi-Dastjerdi N, Soltany‐Rezaee‐Rad M. Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review. Iranian journal of pharmaceutical research [Internet]. 2024 Oct 15 [cited 2026 Mar];23(1). Available from: https://doi.org/10.5812/ijpr-150510
45. Narayanan RR, Durga N, Nagalakshmi S. Impact of Artificial Intelligence (AI) on Drug Discovery and Product Development. Indian Journal of Pharmaceutical Education and Research [Internet]. 2022 Sept 6 [cited 2025 Sept];56. Available from: https://doi.org/10.5530/ijper.56.3s.146
46. Sunil DS. ArtificialIntelligenceInDrugDiscoveryAndFormulation:Transforming PersonalizedMedicine. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 6 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18885510
47. Sunil DS. ArtificialIntelligenceInDrugDiscoveryAndFormulation:Transforming PersonalizedMedicine. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 6 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18885509
48. Arora P, Behera M, Saraf SA, Shukla R. Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics. Current Pharmaceutical Design [Internet]. 2024 June 14 [cited 2025 Nov];30(28):2187–205. Available from: https://doi.org/10.2174/0113816128308066240529121148
49. Medhi B, Sharma H, Kaundal T, Prakash A. Artificial Intelligence: A Catalyst for Breakthroughs in Nanotechnology and Pharmaceutical Research. International Journal of Pharmaceutical Sciences and Nanotechnology [Internet]. 2024 Aug 15 [cited 2025 Dec];17(4):7439–45. Available from: https://doi.org/10.37285/ijpsn.2024.17.4.1
50. Kanakia A, Sale M, Zhao L, Zhu Z. AI In Action: Redefining Drug Discovery and Development. Clinical and Translational Science [Internet]. 2025 Feb 1 [cited 2026 Mar];18(2). Available from: https://doi.org/10.1111/cts.70149
51. jadhav SSP Vishwjit Kisan Rathod, Nagane Abhijeet Ramesh, Mujawar suhana salim*, Dr Rahul ishwara. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN PHARMACEUTICAL RESEARCH: TRANSFORMING DRUG DISCOVERY, FORMULATION DEVELOPMENT, AND QUALITY ASSURANCE. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 2 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18838484
52. jadhav SSP Vishwjit Kisan Rathod, Nagane Abhijeet Ramesh, Mujawar suhana salim*, Dr Rahul ishwara. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN PHARMACEUTICAL RESEARCH: TRANSFORMING DRUG DISCOVERY, FORMULATION DEVELOPMENT, AND QUALITY ASSURANCE. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 2 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18838485
53. Krishnan PS, Krishnan NJS, Dey A, Sivakumar S, Ravichandran S, Bharathi MPG. TECH-DRIVEN TRUST: THE ROLE OF AI AND EMERGING TECHNOLOGIES IN PHARMACEUTICAL QUALITY ASSURANCE. International Journal of Applied Pharmaceutics [Internet]. 2025 Sept 7 [cited 2025 Sept];122–31. Available from: https://doi.org/10.22159/ijap.2025v17i5.54474
54. Carini C, Seyhan AA. Tribulations and future opportunities for artificial intelligence in precision medicine. Journal of Translational Medicine [Internet]. BioMed Central; 2024 Apr 30 [cited 2025 Oct];22(1). Available from: https://doi.org/10.1186/s12967-024-05067-0
55. Jarallah SJ, Almughem FA, Alhumaid NK, Fayez NA, Alradwan I, Alsulami KA, et al. Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. International Journal of Pharmaceutics [Internet]. 2025 May 30 [cited 2026 Jan];680:125789–125789. Available from: https://doi.org/10.1016/j.ijpharm.2025.125789
56. Liu Y, Zhang L, Jiang Z, Xia T, Li P, Wu P, et al. Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development. MedComm [Internet]. 2025 July 30 [cited 2025 Nov];6(8). Available from: https://doi.org/10.1002/mco2.70317
57. Robert K, Kaium O, Alasa L. Generative AI and Pharmaceutical Innovation: Accelerating Drug Discovery with Deep Learning and Predictive Analytics. International Journal of Multidisciplinary Evolutionary Research [Internet]. 2025 Jan 1 [cited 2025 Nov];6(2):44–52. Available from: https://doi.org/10.54660/ijmer.2025.6.2.44-52
58. Husnain A, Rasool S, Saeed A, Hussain HK. Revolutionizing Pharmaceutical Research: Harnessing Machine Learning for a Paradigm Shift in Drug Discovery. International Journal of Multidisciplinary Sciences and Arts [Internet]. 2023 Sept 27 [cited 2025 Oct];2(2):149–57. Available from: https://doi.org/10.47709/ijmdsa.v2i2.2897
59. Nwankwo EI, Emeihe EV, Ajegbile MD, Olaboye JA, Maha CC. AI in personalized medicine: Enhancing drug efficacy and reducing adverse effects. International Medical Science Research Journal [Internet]. 2024 Aug 23 [cited 2025 Sept];4(8):806–33. Available from: https://doi.org/10.51594/imsrj.v4i8.1453
60. Kiriiri GK, Njogu P, Mwangi A. Exploring different approaches to improve the success of drug discovery and development projects: a review. Future Journal of Pharmaceutical Sciences [Internet]. Springer Science+Business Media; 2020 June 23 [cited 2025 Oct];6(1). Available from: https://doi.org/10.1186/s43094-020-00047-9
61. A SI, N. BS. Artificial Intelligence Drug Discovery and Development. Asian Journal of Pharmaceutical Research and Development [Internet]. 2025 Dec 15 [cited 2026 Mar];13(6):119–29. Available from: https://doi.org/10.22270/ajprd.v13i6.1657
62. Bilgin GB, Bilgin C, Burkett BJ, Orme JJ, Childs DS, Thorpe M, et al. Theranostics and artificial intelligence: new frontiers in personalized medicine. Theranostics [Internet]. Ivyspring International Publisher; 2024 Jan 1 [cited 2025 Oct];14(6):2367–78. Available from: https://doi.org/10.7150/thno.94788
63. Gangwal A, Ansari MA, Ahmad I, Azad AK, Kumarasamy V, Subramaniyan V, et al. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Frontiers in Pharmacology [Internet]. 2024 Feb 7 [cited 2025 Oct];15. Available from: https://doi.org/10.3389/fphar.2024.1331062
64. Bhosale SZ Tanuja Tandale, Dr Sujit Kakade, Dr Ashok. Review on Artificial Intelligence (AI) in Pharmaceutical Field. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Feb 22 [cited 2026 Feb]; Available from: https://doi.org/10.5281/zenodo.18730245
65. Bhosale SZ Tanuja Tandale, Dr Sujit Kakade, Dr Ashok. Review on Artificial Intelligence (AI) in Pharmaceutical Field. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Feb 22 [cited 2026 Feb]; Available from: https://doi.org/10.5281/zenodo.18730246
66. Atz K, Cotos L, Isert C, Håkansson M, Focht D, Hilleke M, et al. Prospective de novo drug design with deep interactome learning. Nature Communications [Internet]. 2024 Apr 22 [cited 2025 Oct];15(1). Available from: https://doi.org/10.1038/s41467-024-47613-w
67. Hinkson IV, Madej BD, Stahlberg E. Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery. Frontiers in Pharmacology [Internet]. 2020 June 30 [cited 2025 Oct];11. Available from: https://doi.org/10.3389/fphar.2020.00770
68. Li X, Xing J, Zhang S, Zhou J. Editorial: Advancing drug discovery with AI: drug–target interactions, mechanisms of action, and screening. Frontiers in Pharmacology [Internet]. 2025 Oct 24 [cited 2026 Mar];16:1721323–1721323. Available from: https://doi.org/10.3389/fphar.2025.1721323
69. Ocaña A, Pandiella A, Privat C, Bravo I, Luengo-Oroz M, Amir E, et al. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach. Biomarker Research [Internet]. 2025 Mar 14 [cited 2026 Jan];13(1):45–45. Available from: https://doi.org/10.1186/s40364-025-00758-2
70. Hasselgren C, Oprea TI. Artificial Intelligence for Drug Discovery: Are We There Yet? The Annual Review of Pharmacology and Toxicology [Internet]. Annual Reviews; 2023 Sept 22 [cited 2025 Aug];64(1):527–50. Available from: https://doi.org/10.1146/annurev-pharmtox-040323-040828
71. Potineni B. Generative AI in drug discovery: Accelerating the search for new therapeutics. World Journal of Advanced Engineering Technology and Sciences [Internet]. 2025 Apr 26 [cited 2025 Nov];15(1):1784–94. Available from: https://doi.org/10.30574/wjaets.2025.15.1.0298
72. Bae H, Ji H, Konstantinov K, Sluyter R, Ariga K, Kim YH, et al. Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery. Advanced Materials [Internet]. 2025 Aug 7 [cited 2025 Nov];37(42). Available from: https://doi.org/10.1002/adma.202510239
73. Niazi SK. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives. Drug Design Development and Therapy [Internet]. 2023 Sept 1 [cited 2025 Aug];2691–725. Available from: https://doi.org/10.2147/dddt.s424991
74. Pushkaran AC, Arabi AA. From understanding diseases to drug design: can artificial intelligence bridge the gap? Artificial Intelligence Review [Internet]. 2024 Mar 11 [cited 2025 Oct];57(4). Available from: https://doi.org/10.1007/s10462-024-10714-5
75. Crucitti D, Míguez CP, Arias JÁD, Prada DBF, Orgueira AM. De novo drug design through artificial intelligence: an introduction. Frontiers in Hematology [Internet]. 2024 Jan 25 [cited 2025 Oct];3. Available from: https://doi.org/10.3389/frhem.2024.1305741
76. Bilotta M, Rocca R, Alcaro S. Next-generation drug discovery: The AI revolution in pharmaceutical research. Artificial Intelligence in the Life Sciences [Internet]. 2025 Nov 27 [cited 2025 Dec];8:100149–100149. Available from: https://doi.org/10.1016/j.ailsci.2025.100149
77. Zhavoronkov A, Vanhaelen Q, Oprea TI. Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology? Clinical Pharmacology & Therapeutics [Internet]. Wiley; 2020 Jan 20 [cited 2025 Oct];107(4):780–5. Available from: https://doi.org/10.1002/cpt.1795
78. Naithani U, Guleria V. Integrative computational approaches for discovery and evaluation of lead compound for drug design. Frontiers in Drug Discovery [Internet]. 2024 Apr 5 [cited 2025 Oct];4. Available from: https://doi.org/10.3389/fddsv.2024.1362456
79. Udegbe FC, Ebulue OR, Ebulue CC, Ekesiobi CS. MACHINE LEARNING IN DRUG DISCOVERY: A CRITICAL REVIEW OF APPLICATIONS AND CHALLENGES. Computer Science & IT Research Journal [Internet]. Fair East Publishers; 2024 Apr 17 [cited 2025 Sept];5(4):892–902. Available from: https://doi.org/10.51594/csitrj.v5i4.1048
80. Zhang O, Lin H, Zhang H, Zhao H, Huang Y, Hsieh C, et al. Deep Lead Optimization: Leveraging Generative AI for Structural Modification. Journal of the American Chemical Society [Internet]. American Chemical Society; 2024 Nov 5 [cited 2025 Oct];146(46):31357–70. Available from: https://doi.org/10.1021/jacs.4c11686
81. Khan MK, Raza MA, Shahbaz M, Hussain I, Khan MF, Xie Z, et al. The recent advances in the approach of artificial intelligence (AI) towards drug discovery. Frontiers in Chemistry [Internet]. 2024 May 31 [cited 2025 Aug];12. Available from: https://doi.org/10.3389/fchem.2024.1408740
82. Bahekar S, Bhosale T. Artificial Intelligence in Drug Discovery. The Journal of Medical Research [Internet]. 2025 Sept 22 [cited 2026 Jan];11(6):135–6. Available from: https://doi.org/10.4103/jmr.jmr_26_25
83. Honey E, Khan A. Artificial Intelligence in Drug Discovery & Development. International journal of research and scientific innovation [Internet]. 2025 Nov 6 [cited 2026 Mar];12(10):1337–49. Available from: https://doi.org/10.51244/ijrsi.2025.1210000118
84. Zeb S, FNU N, Abbasi N, Fahad M. AI in Healthcare: Revolutionizing Diagnosis and Therapy. International Journal of Multidisciplinary Sciences and Arts [Internet]. 2024 Aug 17 [cited 2025 Oct];3(3):118–28. Available from: https://doi.org/10.47709/ijmdsa.v3i3.4546
85. Unogwu OJ, Ike M, Joktan OO. Employing Artificial Intelligence Methods in Drug Development: A New Era in Medicine. Mesopotamian Journal of Artificial Intelligence in Healthcare [Internet]. 2023 Oct 20 [cited 2025 Oct];2023:52–6. Available from: https://doi.org/10.58496/mjaih/2023/010
86. Mehran MJ, Mohammadzadeh S, Bolideei M, Barzigar R, Haider KH, Jadgal N, et al. Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation. Drug Development Research [Internet]. 2026 Feb 2 [cited 2026 Feb];87(2). Available from: https://doi.org/10.1002/ddr.70229
87. Mintaş Ş, Sevimli-Gür C. Artificial Intelligence Applications in Drug Discovery and Research. DergiPark (Istanbul University) [Internet]. 2024 Nov 18 [cited 2025 Oct]; Available from: https://dergipark.org.tr/en/pub/jaida/issue/89048/1587347
88. Raut1 SMR. Revolutionizing Formulation Design: The Power of Ai-Driven De Novo Approaches. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 3 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18851647
89. Kumar PKK, Yadagiri PY, Eswaramoorthi ME, Jaganathan S, Saravanan J, M V. Artificial Intelligence (AI): Drug Design and Formulation . Indian Journal of Pharmaceutical Chemistry and Analytical Techniques [Internet]. 2026 Feb 24 [cited 2026 Mar];2(1):1–10. Available from: https://doi.org/10.64062/ijpcat.vol2.issue1.1
90. Raut1 SMR. Revolutionizing Formulation Design: The Power of Ai-Driven De Novo Approaches. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2026 Mar 3 [cited 2026 Mar]; Available from: https://doi.org/10.5281/zenodo.18851648
91. Bandgar. SC kale* Sayali S More, DrSA. THE FUTURE OF DRUG AND FORMULATION INNOVATION: AI-DRIVEN STRUCTURE-BASED DE NOVO DESIGN PARADIGMS. In: Zenodo (CERN European Organization for Nuclear Research) [Internet]. European Organization for Nuclear Research; 2026 [cited 2026 Jan]. Available from: https://doi.org/10.5281/zenodo.18225162
92. Saha G. Artificial Intelligence (AI) in Formulation Development. In 2024 [cited 2025 Nov]. p. 459–81. Available from: https://doi.org/10.69613/tkh3gv85
93. G.3 HH *1 Kottai Muthu A 2, Alagu Manivasagam. Artificial Intelligence and Machine Learning in Drug Formulation Development. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 12 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17589193
94. Chauhan SB, Singh I, Singh M, Jain chirag. AI-Powered Excipient Innovation: Transforming Drug Design, ADMETProfiling, and Formulation Developmen. Current Topics in Medicinal Chemistry [Internet]. 2026 Mar 27 [cited 2026 Mar];26. Available from: https://doi.org/10.2174/0115680266431788260223072453
95. Zhang Z, Xiang Y, Laforêt J, Spasojević I, Fan P, Heffernan A, et al. TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery. ACS Nano [Internet]. 2025 Sept 11 [cited 2026 Mar];19(37):33288–96. Available from: https://doi.org/10.1021/acsnano.5c09066
96. Chan A, Kirtane AR, Qu QR, Huang X, Woo J, Subramanian DA, et al. Designing lipid nanoparticles using a transformer-based neural network. Nature Nanotechnology [Internet]. 2025 Aug 15 [cited 2025 Oct]; Available from: https://doi.org/10.1038/s41565-025-01975-4
97. Bais SDP Yogesh B Raut, Sanjay K. RECENT ADVANCEMENT IN USE OF COMPUTER IN PHARMACEUTICAL FORMULATION DEVELOPMENT. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Dec 10 [cited 2025 Dec]; Available from: https://doi.org/10.5281/zenodo.17878680
98. Bais SDP Yogesh B Raut, Sanjay K. RECENT ADVANCEMENT IN USE OF COMPUTER IN PHARMACEUTICAL FORMULATION DEVELOPMENT. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Dec 10 [cited 2025 Dec]; Available from: https://doi.org/10.5281/zenodo.17878681
99. Dong J, Wu Z, Xu H, Ouyang D. FormulationAI: a novel web-based platform for drug formulation design driven by artificial intelligence. Briefings in Bioinformatics [Internet]. 2023 Nov 22 [cited 2025 Dec];25(1). Available from: https://doi.org/10.1093/bib/bbad419
100. Siepmann J, Basit AW, Rades T. Pharmaceutical Technology in Europe. International Journal of Pharmaceutics [Internet]. 2021 Dec 30 [cited 2025 Aug];613:121441–121441. Available from: https://doi.org/10.1016/j.ijpharm.2021.121441
101. Tanga S, Ramburrun P, Aucamp M. From Liquid SNEDDS to Solid SNEDDS: A Comprehensive Review of Their Development and Pharmaceutical Applications. The AAPS Journal [Internet]. Springer Science+Business Media; 2025 Oct 30 [cited 2025 Nov];28(1). Available from: https://doi.org/10.1208/s12248-025-01167-x
102. Zaslavsky J, Allen C. A dataset of formulation compositions for self-emulsifying drug delivery systems. Scientific Data [Internet]. 2023 Dec 20 [cited 2025 July];10(1). Available from: https://doi.org/10.1038/s41597-023-02812-w
103. Reker D, Rybakova Y, Kirtane AR, Cao R, Yang JW, Navamajiti N, et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nature Nanotechnology [Internet]. 2021 Mar 25 [cited 2025 Oct];16(6):725–33. Available from: https://doi.org/10.1038/s41565-021-00870-y
104. Pan Y, Mi R, Bian W, Wang Z, Zhao M, Li Z, et al. Harnessing the Power of Artificial Intelligence for Pharmaceutics: From Pharmacokinetics Prediction, Formulation, to Manufacturing. Pharmaceutical Fronts [Internet]. 2026 Feb 27 [cited 2026 Mar];8(1). Available from: https://doi.org/10.1055/a-2790-6937
105. Nagpure N, Askar D, Kale DS, Raut H, Rasala T. In-silico pharmaceutics: Quantum simulations for next-generation dosage form design. International Journal of Pharmaceutical Research and Development [Internet]. 2025 July 1 [cited 2026 Mar];7(2):398–405. Available from: https://doi.org/10.33545/26646862.2025.v7.i2e.201
106. G.3 HH *1 Kottai Muthu A 2, Alagu Manivasagam. Artificial Intelligence and Machine Learning in Drug Formulation Development. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Nov 12 [cited 2025 Nov]; Available from: https://doi.org/10.5281/zenodo.17589192
107. Askr H, Elgeldawi E, Ella HA, Elshaier YAMM, Gomaa MM, Hassanien AE. Deep learning in drug discovery: an integrative review and future challenges. Artificial Intelligence Review [Internet]. 2022 Nov 17 [cited 2025 Aug];56(7):5975–6037. Available from: https://doi.org/10.1007/s10462-022-10306-1
108. Research MJ of M. Artificial Intelligence in pharmaceutical sciences: Transforming drug discovery, formulation, and manufacturing. Zenodo (CERN European Organization for Nuclear Research) [Internet]. 2025 Dec 15 [cited 2025 Dec]; Available from: https://doi.org/10.5281/zenodo.17945148
109. Wu P, Zang P. Artificial Intelligence in Pharmaceutical Formulation: A Comprehensive Review. Applied Artificial Intelligence Research [Internet]. 2025 Dec 2 [cited 2026 Mar];1(3). Available from: https://doi.org/10.65455/nshrsr55
110. Wei Z, Zhuo S, Zhang Y, Wu L, Gao X, He S, et al. Machine learning reshapes the paradigm of nanomedicine research. Acta Pharmaceutica Sinica B [Internet]. 2025 May 1 [cited 2026 Mar]; Available from: https://doi.org/10.1016/j.apsb.2025.05.014
111. Malik MN, Mali S, Surve P, Londhe P, Komarol H. Artificial intelligence as an innovative tool in nanotechnology for drug delivery. International Journal of Pharmacy and Pharmaceutical Science [Internet]. 2026 Mar 1 [cited 2026 Mar];8(3):59–63. Available from: https://doi.org/10.33545/26647222.2026.v8.i3a.333
112. Edriss AA, Yarra S, Vomo JA, Ismael K, Elshiekh YB. AI-powered nano formulation: revolutionizing drug development and delivery. International Journal of Science and Research Archive [Internet]. 2025 Feb 28 [cited 2025 Dec];14(2):1501–12. Available from: https://doi.org/10.30574/ijsra.2025.14.2.0491
113. Prusty A, Panda SK. The Revolutionary Role of Artificial Intelligence (AI) in Pharmaceutical Sciences. Indian Journal of Pharmaceutical Education and Research [Internet]. 2024 Aug 10 [cited 2025 Aug];58. Available from: https://doi.org/10.5530/ijper.58.3s.78
114. Abdalla Y, Taub MA, Hilton E, Akkaraju P, Milanovic A, Orlu M, et al. VECT-GAN: A variationally encoded generative model for overcoming data scarcity in pharmaceutical science. arXiv (Cornell University) [Internet]. 2025 Jan 15 [cited 2025 Sept]; Available from: http://arxiv.org/abs/2501.08995
115. Baena JC, Victoria J, Toro-Pedroza A, Aragón CC, Ortiz‐Guzman J, García-Robledo JE, et al. Smart CAR-T Nanosymbionts: archetypes and proto-models. Frontiers in Immunology [Internet]. Frontiers Media; 2025 Aug 12 [cited 2025 Oct];16. Available from: https://doi.org/10.3389/fimmu.2025.1635159
116. Han Y, Kim DH, Pack SP. Nanomaterials in Drug Delivery: Leveraging Artificial Intelligence and Big Data for Predictive Design. International Journal of Molecular Sciences [Internet]. 2025 Nov 17 [cited 2026 Mar];26(22):11121–11121. Available from: https://doi.org/10.3390/ijms262211121
117. Kantesaria R, Panda HS. A Review on AI-Based Data-Driven Models for Optimization of Nanocarriers as Drug Delivery Systems. ACS Biomaterials Science & Engineering [Internet]. 2026 Feb 11 [cited 2026 Mar];12(3):1397–418. Available from: https://doi.org/10.1021/acsbiomaterials.5c01998
118. Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, et al. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduction and Targeted Therapy [Internet]. Springer Nature; 2024 Feb 21 [cited 2025 Oct];9(1). Available from: https://doi.org/10.1038/s41392-024-01745-z
119. Wei XX, Jiang Y, Chenwu F, Li Z, Wan J, Li Z, et al. Synergistic Ferroptosis–Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization. Nano-Micro Letters [Internet]. Springer Science+Business Media; 2025 Sept 2 [cited 2025 Sept];18(1). Available from: https://doi.org/10.1007/s40820-025-01862-6
120. Sahu RC, Arora S, Kumar D, Agrawal AK. Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery. Med Research [Internet]. 2025 Nov 17 [cited 2026 Mar];2(1):130–56. Available from: https://doi.org/10.1002/mdr2.70043
121. Okafor NI, Igbokwe NN, Onohuean H, Faya M, Choonara YE. Artificial Intelligence-Driven Development and Characterization of Nanomedicine. BioNanoScience [Internet]. 2026 Mar 17 [cited 2026 Mar];16(4). Available from: https://doi.org/10.1007/s12668-026-02476-x
122. Gao XJ, Gao XJ, Ciura K, Ma Y, Mikołajczyk A, Jagiełło K, et al. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials [Internet]. 2024 Sept 10 [cited 2026 Mar];36(45). Available from: https://doi.org/10.1002/adma.202407793
123. Wu C, Xu Y, Fang J, Li Q. Machine Learning in Biomaterials, Biomechanics/Mechanobiology, and Biofabrication: State of the Art and Perspective. Archives of Computational Methods in Engineering [Internet]. 2024 May 4 [cited 2025 Oct]; Available from: https://doi.org/10.1007/s11831-024-10100-y
124. Padmini S, Amaran S, Sreekumar K, Kalaivani J, Iniyan S. Artificial Intelligence-Enhanced Nanomedicine Design and Deep Reinforcement Learning in Pharmacokinetics. In: Advances in medical technologies and clinical practice book series [Internet]. IGI Global; 2024 [cited 2025 Dec]. p. 135–68. Available from: https://doi.org/10.4018/979-8-3693-3212-2.ch006
125. Kumar A, Qasim S, Sharma A, Gugulothu D, Verma S. Machine Learning Algorithm for Nanomedicine: AI Curated Nanocarriers for Cancer Treatment. Current Pharmaceutical Design [Internet]. 2026 Mar 12 [cited 2026 Mar];32. Available from: https://doi.org/10.2174/0113816128413703251124110442
126. Aundhia C, Parmar G, Talele C, Kumari M, Gupta G. Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing. Current Drug Targets [Internet]. 2026 Jan 19 [cited 2026 Jan];27. Available from: https://doi.org/10.2174/0113894501430905251210054617
127. Li H, Yue F, Luo Q, Li Z, Li X, Gan H, et al. Stimuli-activatable nanomedicine meets cancer theranostics. Theranostics [Internet]. Ivyspring International Publisher; 2023 Jan 1 [cited 2025 Aug];13(15):5386–417. Available from: https://doi.org/10.7150/thno.87854
128. Yousfan A, Rahwanji MJA, Hanano A, Al-Obaidi H. A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques. Molecular Pharmaceutics [Internet]. 2023 Dec 7 [cited 2025 Aug];21(1):333–45. Available from: https://doi.org/10.1021/acs.molpharmaceut.3c00880
129. Azimi S. Intelligent nanoparticle design: Unlocking the potential of AI for transformative drug delivery. Current Opinion in Biomedical Engineering [Internet]. 2025 Oct 15 [cited 2026 Jan];36:100625–100625. Available from: https://doi.org/10.1016/j.cobme.2025.100625
130. Singh AV, Varma M, Laux P, Choudhary S, Datusalia AK, Gupta N, et al. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review. Archives of Toxicology [Internet]. Springer Science+Business Media; 2023 Mar 7 [cited 2025 Oct];97(4):963–79. Available from: https://doi.org/10.1007/s00204-023-03471-x
131. Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nature Reviews Methods Primers [Internet]. 2022 Apr 14 [cited 2025 Oct];2(1). Available from: https://doi.org/10.1038/s43586-022-00104-y
132. Đorđević S, Medel M, Conejos‐Sánchez I, Carreira B, Pozzi S, Acúrcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery and Translational Research [Internet]. Springer Science+Business Media; 2021 July 23 [cited 2025 Oct];12(3):500–25. Available from: https://doi.org/10.1007/s13346-021-01024-2
133. Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. Journal of Nanobiotechnology [Internet]. BioMed Central; 2022 Aug 31 [cited 2025 Oct];20(1). Available from: https://doi.org/10.1186/s12951-022-01605-4
134. Bardhan NM. Nanomaterials in diagnostics, imaging and delivery: Applications from COVID-19 to cancer. MRS Communications [Internet]. Springer Nature; 2022 Oct 17 [cited 2025 Sept];12(6):1119–39. Available from: https://doi.org/10.1557/s43579-022-00257-7
135. Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan RS, Dufès C, et al. On the issue of transparency and reproducibility in nanomedicine [Internet]. Vol. 14, Nature Nanotechnology. Nature Portfolio; 2019 [cited 2025 Aug]. p. 629–35. Available from: https://doi.org/10.1038/s41565-019-0496-9
136. Paunovska K, Loughrey D, Sago CD, Langer R, Dahlman JE. Using Large Datasets to Understand Nanotechnology. Advanced Materials [Internet]. 2019 Aug 20 [cited 2025 Oct];31(43). Available from: https://doi.org/10.1002/adma.201902798
137. Jones D, Ghandehari H, Facelli JC. A review of the applications of data mining and machine learning for the prediction of biomedical properties of nanoparticles. Computer Methods and Programs in Biomedicine [Internet]. Elsevier BV; 2016 Apr 30 [cited 2025 Sept];132:93–103. Available from: https://doi.org/10.1016/j.cmpb.2016.04.025
138. Tade RS, Jain SN, Satyavijay JT, Shah PN, Bari TD, Patil TM, et al. Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review. Nano Biomedicine and Engineering [Internet]. 2023 Dec 8 [cited 2025 Oct];16(1):64–77. Available from: https://doi.org/10.26599/nbe.2023.9290043
139. Crisafulli S, Ciccimarra F, Bellitto C, Carollo M, Carrara E, Stagi L, et al. Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities. Frontiers in Drug Safety and Regulation [Internet]. Frontiers Media; 2024 Mar 18 [cited 2025 Sept];4. Available from: https://doi.org/10.3389/fdsfr.2024.1356405
140. Somara S, Joshi AM, Mitra K, Desai S, Lundberg MS, Bhasin S, et al. Artificial Intelligence in Biotechnology and Pharmaceuticals: Evolution, Applications, and Regulatory Frontiers. Current Stem Cell Reports [Internet]. 2025 Nov 1 [cited 2025 Nov];11(1). Available from: https://doi.org/10.1007/s40778-025-00249-y
141. Health TLD. Fixing cracks in the artificial intelligence drug development pipeline. The Lancet Digital Health [Internet]. 2025 July 1 [cited 2026 Feb];7(7):100897–100897. Available from: https://doi.org/10.1016/j.landig.2025.100897
142. Zaslavsky J, Bannigan P, Allen C. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence. Expert Opinion on Drug Delivery [Internet]. 2023 Jan 16 [cited 2025 Nov];20(2):241–57. Available from: https://doi.org/10.1080/17425247.2023.2167978
143. Mazumdar H, Khondakar KR, Das S, Harder A, Kaushik A. Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. Expert Opinion on Drug Delivery [Internet]. 2024 Dec 8 [cited 2025 Nov];22(1):85–108. Available from: https://doi.org/10.1080/17425247.2024.2440618
144. Gupta YD, Mackeyev Y, Krishnan S, Bhandary S. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics. Cancer Nanotechnology [Internet]. 2024 Jan 31 [cited 2025 Oct];15(1). Available from: https://doi.org/10.1186/s12645-024-00250-w
145. Haramshahi SMA, Hamblin MR, Ravesh RK, Sadr H, Ahmadirad N, Mehrabi F, et al. Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization. Journal of Materials Science Materials in Medicine [Internet]. Springer Science+Business Media; 2025 Oct 14 [cited 2025 Oct];36(1). Available from: https://doi.org/10.1007/s10856-025-06947-7
146. Sampene AK, Nyirenda F. Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China. Future Journal of Pharmaceutical Sciences [Internet]. 2024 Apr 7 [cited 2025 Oct];10(1). Available from: https://doi.org/10.1186/s43094-024-00632-2
147. Sarkar S, Das D. Artificial Intelligence in Nanomedicine Formulation and Applications. In: BENTHAM SCIENCE PUBLISHERS eBooks [Internet]. 2025 [cited 2026 Jan]. p. 171–200. Available from: https://doi.org/10.2174/9798898813123125010012
148. Zhou H, Xu J, Qin X, Zhang J, Zou W, Shakouri M, et al. New Frontiers in AI-Nano Converged Platforms for Intelligent Diagnostics, Therapeutics, and Safety Evaluation. Chem & Bio Engineering [Internet]. 2026 Mar 28 [cited 2026 Mar]; Available from: https://doi.org/10.1021/cbe.5c00188
149. Hwang N, Lim DC, Goh TS, Kang J, Kim J, Kim S, et al. Recent advances in theranostic nanomaterials for overcoming traumatic brain injury. Journal of Nanobiotechnology [Internet]. BioMed Central; 2025 Oct 29 [cited 2025 Oct];23(1). Available from: https://doi.org/10.1186/s12951-025-03685-4
150. Zhang P, Guo Z, Ullah S, Melagraki G, Afantitis A, Lynch I. Nanotechnology and artificial intelligence to enable sustainable and precision agriculture. Nature Plants [Internet]. Nature Portfolio; 2021 June 24 [cited 2025 Aug];7(7):864–76. Available from: https://doi.org/10.1038/s41477-021-00946-6
151. Singh AV, Bhardwaj P, Upadhyay AK, Pagani A, Upadhyay J, Bhadra J, et al. Navigating regulatory challenges in molecularly tailored nanomedicine. 2024 Apr 25 [cited 2025 Oct];1(2):124–34. Available from: https://doi.org/10.37349/ebmx.2024.00009
152. Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Narayanan J, Rao DP, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Molecular Cancer [Internet]. BioMed Central; 2023 Oct 9 [cited 2025 Aug];22(1). Available from: https://doi.org/10.1186/s12943-023-01865-0
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Ritika Sharma, Harmeet Singh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.